Francesco Rinaldi Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

6/2003

Maillard reaction products inhibit oxidation of human low-density lipoproteins in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesco Rinaldi Research Topics

Disease

1	Malaria 02/2024
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2023
1	Genomic Instability 07/2022
1	Disease Progression 10/2021
1	Bites and Stings (Sting) 01/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019
1	Hemorrhage 12/2010
1	Fever (Fevers) 01/2008
1	Arthralgia (Joint Pain) 01/2008
1	Exanthema (Rash) 01/2008
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2003

Drug/Important Bio-Agent (IBA)

1	Transaminases (Aminotransferases)IBA 02/2024
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2023
1	talazoparibIBA 12/2023
1	Proteins (Proteins, Gene)FDA Link 07/2022
1	Cyclophilin AIBA 10/2021
1	Indicators and Reagents (Reagents)IBA 01/2019
1	Muromonab-CD3 (Muromonab CD3)FDA Link 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	AntibodiesIBA 01/2019
1	Immunoglobulin FragmentsIBA 01/2019
1	Ginkgo biloba extract VR456IBA 12/2010
1	AnticoagulantsIBA 12/2010
1	Nonprescription Drugs (Patent Medicines)IBA 12/2010
1	Ginkgo biloba extract (Rokan)IBA 12/2010
1	Terpenes (Terpenoids)IBA 12/2010
1	Immunoglobulin M (IgM)IBA 01/2008
1	LDL Lipoproteins (beta Lipoproteins)IBA 06/2003
1	oxidized low density lipoproteinIBA 06/2003
1	AntioxidantsIBA 06/2003